Related by context. All words. (Click for frequent words.) 58 antioxidant supplementation 58 Conclusions 57 authors hypothesized 57 comorbid depression 57 comorbid disorders 56 familial clustering 56 prognostic indicators 56 prostate cancer CaP 56 pharmacological interventions 56 etiology 56 nephron sparing surgery 55 pharmacologic treatments 55 familial predisposition 55 neurocognitive function 55 etiologic 55 adjuvant therapies 55 CVD mortality 55 aetiology 55 comorbidities 55 predisposing factor 54 pharmacological therapies 54 β blockers 54 causal pathway 54 CONCLUSIONS 54 Genetic predisposition 54 morbidity mortality 54 comorbidity 54 postoperative radiotherapy 54 cardiovascular morbidity 54 residual confounding 53 psychiatric comorbidity 53 prognostic indicator 53 thromboprophylaxis 53 carotid plaques 53 subgroup analyzes 53 nutrient supplementation 53 postoperative AF 53 socioeconomic status SES 53 clinicopathologic 53 testosterone supplementation 53 comorbid conditions 53 metabolic abnormalities 53 neurodevelopmental outcomes 53 etiologic factors 53 psychiatric comorbidities 53 venous thromboembolic disease 53 longitudinal studies 53 confounder 53 thyrotropin levels 53 macrovascular disease 53 vitamin D supplementation 53 carotid atherosclerosis 53 prognostic significance 53 carotid bruit 53 neuropsychological impairments 53 utero exposure 53 EGFR mutation status 53 myocardial dysfunction 53 liver transplant recipients 53 generalizability 53 HIV HCV coinfected 53 paclitaxel eluting stents 53 nonpharmacologic 53 incidence 53 neurodevelopmental outcome 52 shorter telomere length 52 epidemiologic studies 52 psychosocial functioning 52 differential gene expression 52 biologic plausibility 52 socioeconomic gradient 52 poststroke depression 52 ovarian suppression 52 thyroid hormone levels 52 antibiotic prophylaxis 52 T1DM 52 sequelae 52 serum lipid levels 52 univariate analyzes 52 randomized controlled trials 52 oncologic outcomes 52 potentially modifiable 52 multivariate analyzes 52 syndromal 52 pharmacologic intervention 52 dietary antioxidants 52 androgen deficiency 52 psychiatric morbidity 52 etiological 52 pharmacological approaches 52 familial aggregation 52 APOE genotype 52 colorectal carcinogenesis 52 nonalcoholic steatohepatitis NASH 52 androgen suppression 52 thyroid nodules 52 generalizable 52 morbidities 52 prospective cohort 52 comorbid illnesses 52 dietary calcium intake 52 cranial irradiation 52 prevalence 52 neuropsychological deficits 52 subclinical hypothyroidism 52 H. pylori eradication 52 therapeutic interventions 52 bicuspid aortic valves 52 antiplatelet therapies 52 nodal metastases 52 non pharmacological interventions 52 Subgroup analyzes 52 randomized trials 52 colorectal adenoma 52 Radical prostatectomy 52 authors hypothesize 52 colorectal neoplasia 52 primary hyperparathyroidism 52 elevated CRP 52 cerebral infarction 52 ConclusionThis 52 coronary calcification 52 nonfatal MI 52 meta analytic review 52 adenoidectomy 52 underlying pathophysiology 51 histologic subtype 51 adjuvant therapy 51 subclinical atherosclerosis 51 Vitamin D supplementation 51 unmeasured confounders 51 cirrhotic patients 51 androgen deprivation 51 spontaneous regression 51 neurocognitive impairment 51 thromboembolic disease 51 reinfarction 51 NAT2 51 researchers hypothesized 51 chlamydial infection 51 lipid lowering therapy 51 generalisable 51 atopic sensitization 51 postnatally 51 ICD implantation 51 genetic polymorphisms 51 neurological abnormalities 51 colorectal adenomas 51 prepubertal 51 sociodemographic factors 51 oral anticoagulation 51 colorectal neoplasms 51 perioperative morbidity 51 FGFR2 gene 51 cardiovascular mortality 51 multivariate adjustment 51 lymph node dissection 51 preoperative diagnosis 51 sonographic appearance 51 generalisability 51 comorbid psychiatric disorders 51 neurocognitive functioning 51 chronicity 51 carotid IMT 51 root caries 51 underdiagnosis 51 sociodemographic characteristics 51 beta carotene supplementation 51 antitumor effect 51 CYP#D# genotype 51 metaanalysis 51 probiotic supplementation 51 sonographic diagnosis 51 confounders 51 intracerebral haemorrhage 51 perinatal outcomes 51 antimicrobial prophylaxis 51 Kaplan Meier curve 51 Meta analyzes 51 perfusion abnormalities 51 undergoing radical prostatectomy 51 RCTs 51 alexithymia 51 predisposing factors 51 abstinent alcoholics 51 antithrombotic therapy 51 calcium supplementation 51 chronic periodontitis 51 retrospective cohort study 51 dietary acrylamide 51 inversely associated 51 mild analgesics 51 ischemic lesions 51 randomized controlled trial 50 HER2 expression 50 neuropsychological functioning 50 perioperative mortality 50 perioperative complications 50 psychotherapeutic interventions 50 stratifying patients 50 beta blocker therapy 50 dietary patterns 50 F FDG PET 50 inverse association 50 homocysteine concentrations 50 endoscopic ultrasonography 50 coadministration 50 coinfection 50 Observational studies 50 pleiotropic effects 50 RE LY trial 50 interobserver 50 diathesis 50 antihypertensive therapy 50 SRBD 50 epidemiologic 50 airway responsiveness 50 Prognostic factors 50 coinfected patients 50 allogeneic HSCT 50 noncardiac 50 folate supplementation 50 serum lipid 50 morbidity 50 gallstone disease 50 LV dysfunction 50 strongest predictors 50 multivariate Cox 50 postoperative atrial fibrillation 50 Calcium intake 50 androgen ablation 50 platelet activation 50 renoprotective 50 extensive metabolizers 50 logistic regression model 50 penetrance 50 VUR 50 cardioprotective effects 50 meta analysis 50 scintigraphic 50 adenotonsillectomy 50 prothrombotic 50 KRAS mutation status 50 serum PTH 50 recurrent venous thromboembolism 50 serum folate concentrations 50 childhood acute lymphoblastic 50 statistically significant predictor 50 HNSCC 50 dietary interventions 50 prospective observational studies 50 unmeasured confounding 50 heritable variation 50 plasma pharmacokinetics 50 antiarrhythmic drug 50 virological response 50 Epidemiological studies 50 abnormal lipid 50 carotid stenosis 50 unmeasured factors 50 isoflavone supplement 50 multiple logistic regression 50 VTE prophylaxis 50 GH deficiency 50 antihypertensive medication 50 psychopharmacologic 50 polyp recurrence 50 confounding variables 50 nonfasting triglyceride levels 50 conventional angiography 50 autonomic dysfunction 50 adiposity 50 randomized clinical 50 symptomatic VTE 50 Socioeconomic status 50 pelvic lymphadenectomy 50 TT genotype 50 prognostic markers 50 Comorbidities 50 prostate carcinogenesis 49 vesicoureteral reflux 49 androgen depletion 49 limiting generalizability 49 hydroxyvitamin D concentrations 49 antenatal depression 49 HRQOL 49 lowest tertile 49 nonalcoholic steatohepatitis 49 clinicopathological 49 periprocedural MI 49 serum uric acid 49 BRCA mutation carriers 49 lymphadenectomy 49 colonoscopic 49 chemopreventive agent 49 serum concentrations 49 predictive biomarker 49 pathophysiological mechanisms 49 metaplasia 49 multivitamin supplementation 49 tumor histology 49 curative resection 49 virologic responses 49 hemodynamically significant 49 adenoma recurrence 49 medication nonadherence 49 neurocognitive deficits 49 contralateral breast 49 obese postmenopausal 49 postoperative morbidity 49 gastric cardia 49 vitamin D insufficiency 49 correlational 49 incomplete revascularization 49 adiponectin levels 49 adenomatous 49 highly heritable 49 urolithiasis 49 bilateral oophorectomy 49 posttreatment 49 intracranial stenosis 49 advanced neoplasia 49 topical NSAIDs 49 ICD therapy 49 multifactorial 49 meta regression 49 FDG PET 49 CHD coronary 49 BARI 2D 49 preterm neonates 49 DHEA supplementation 49 insulin sensitizing drug 49 hemorrhagic complications 49 chronic thromboembolic pulmonary 49 prospective longitudinal 49 maturational 49 logistic regression models 49 pretest probability 49 pathophysiological 49 thrombotic complications 49 aldosterone antagonists 49 Lp lipoprotein 49 histopathological 49 IPAH 49 adjuvant radiotherapy 49 #F FDG PET 49 CYP#D# inhibitor 49 pathophysiology 49 surgical debulking 49 prospective randomized 49 subclinical 49 antiplatelet therapy 49 spontaneous preterm birth 49 thrombolytic therapy 49 cerebellar vermis 49 germline mutations 49 dietary folate intake 49 phosphorus binders 49 hippocampal volume 49 % CI #.#-#.# [008] 49 subtrochanteric 49 guideline concordant 49 endophenotypes 49 viable myocardium 49 statin therapy 49 brain infarcts 49 leiomyomas 49 stress echocardiography 49 CHD mortality 49 KIF6 carriers 49 observational cohort 49 kidney allograft 49 researchers hypothesize 49 serum vitamin D 49 vitamin supplementation 49 OSAHS 49 undergoing coronary angiography 49 substudy 49 KRAS status 49 EEG abnormalities 49 perioperatively 49 oncological outcomes 49 serum estradiol 49 IDH mutations 49 choline intake 49 psychosocial stressors 49 thiopurine 49 Chronic Heart Failure 49 developmental neurotoxicity 49 hyperplastic polyps 49 interpersonal psychotherapy 49 multivariate analysis 49 eculizumab therapy 49 antiangiogenic therapy 49 spinal metastases 49 tirofiban 49 HbF 49 obese adolescents 49 hypoxemia 49 premenopausal women 49 gonococcal infections 49 LNG IUS 49 teratogenic 49 LUTS 49 nonpregnant women 49 affective disorders 49 chromium supplementation 49 lignan intake 49 symptomatic intracerebral hemorrhage 49 immunostimulatory effects 49 clinicopathological features 49 empiric 49 meta analytic 49 tumor subtype 49 depressive symptoms 49 radiochemotherapy 49 locoregional recurrence 49 dietary intake 49 non fasting triglycerides 49 functional gastrointestinal disorders 49 VADT 49 somatoform disorders 49 ELBW infants 49 epidemiologically 49 HGPIN 49 acute myocardial infarctions 49 artifactual 49 Boston DbTechNo Results 49 nonischemic 49 menstrual irregularity 49 middle ear effusion 49 adjuvant radiation 49 motor neuron degeneration 49 folate intake 49 LAGB 49 urothelial carcinoma 49 microvascular dysfunction 49 premorbid 49 Zinc supplementation 48 artery stenosis 48 antitumor efficacy 48 HMG CoA reductase inhibitors 48 highest tertile 48 biochemical recurrence 48 cervical lesions 48 nondepressed 48 Epidemiologic studies 48 renal tumors 48 causal inference 48 GABRA2 48 urinary excretion 48 MMSE scores 48 lipid levels 48 hematopoietic cancers 48 multivessel disease 48 bronchopulmonary dysplasia BPD 48 adrenocortical 48 neonatal morbidity 48 cytologic 48 presymptomatic 48 transurethral resection 48 symptomatology 48 perinatal complications 48 surrogate markers 48 initiating antiretroviral therapy 48 postdischarge 48 supplementation 48 liver metastasis 48 prostate carcinoma 48 pharmacokinetic interactions 48 HIV seropositive 48 asthma exacerbations 48 Randomized clinical trials 48 pCR 48 chromosomal rearrangement 48 metabolic abnormality 48 hypertension diabetes mellitus 48 locoregional 48 psychosocial outcomes 48 acetabular fractures 48 Chronic pancreatitis 48 concomitant 48 Kaplan Meier analysis 48 chronic rhinosinusitis 48 thyroid carcinoma 48 hypothesized 48 neuropsychiatric symptoms 48 risk stratification 48 adrenalectomy 48 longitudinal cohort study 48 angina myocardial infarction 48 habitual snoring 48 H pylori 48 serum GGT 48 adjuvant tamoxifen 48 SNP rs# [002] 48 periodontal infections 48 multivariate logistic regression 48 gastric carcinogenesis 48 renal scarring 48 pancreatectomy 48 atherosclerosis regression 48 pharmacological treatments 48 atherothrombotic 48 angiographically 48 intratympanic 48 thoracoscopic lobectomy 48 obstructive CAD 48 calculi 48 chemosensitivity 48 myocardial viability 48 genomewide 48 VLBW 48 postoperative hemorrhage 48 randomized controlled trials RCTs 48 NATRECOR ® 48 BRCA2 mutation carriers 48 MMSE score 48 ExTRACT TIMI 48 postoperative complication 48 SLNB 48 cortical activation 48 hereditary predisposition 48 catheter angiography 48 5 HTTLPR 48 metachronous 48 sensory gating 48 hepatorenal syndrome 48 adenocarcinoma histology 48 postmenopausal estrogen 48 femoral neck fracture 48 Topical corticosteroids 48 depressive symptomatology 48 cervical neoplasia 48 posttransplant 48 KRAS variant 48 cervical lymph nodes 48 genotypic 48 Achilles tendon ruptures 48 antidiabetic medications 48 logistic regression analyzes 48 radiographic findings 48 hsCRP levels 48 p = .# [002] 48 thyrotropin 48 rCBF 48 atherosclerotic renal artery stenosis 48 neuronal dysfunction 48 hyperuricaemia 48 antiarrhythmic medications 48 aortic atherosclerosis 48 prefrontal regions 48 TNF blocker therapy 48 precursor lesions 48 CSF biomarkers 48 antidepressive 48 thromboembolic 48 NHANES III 48 genetic susceptibilities 48 antidiabetic therapy 48 abnormal lipid levels 48 thienopyridine 48 endothelial activation 48 BMI z 48 tumor excision 48 postoperative mortality 48 VT VF 48 colorectal polyps 48 nonrandomized 48 pathogenic mechanisms 48 nonoperative treatment 48 BERKELEY CA UroToday.com 48 testicular germ cell 48 conditional logistic regression 48 antiangiogenic agents 48 predictive validity 48 lipid elevations 48 Hilakivi Clarke 48 neuropathological 48 chest radiography 48 knee osteoarthritis OA 48 virologic 48 MGUS 48 BRCA1 mutations 48 NAFLD 48 hippocampal atrophy 48 pharmacological intervention 48 acetabular dysplasia 48 retrospective cohort 48 zinc supplementation 48 intima media thickness 48 multivariable analysis 48 CYP #A# 48 subsyndromal 48 heterozygotes 48 Depressive symptoms 48 electroencephalographic 48 observational cohort study 48 anticoagulation 48 cystectomy 48 hyperacute 48 clinically relevant 48 hyperhomocysteinemia 48 riociguat 48 carotid angioplasty 48 Adjuvant chemotherapy 48 perinatal morbidity 48 epoetin therapy 48 dietary modification 48 extramedullary 48 transrectal ultrasound guided 48 antithrombotic therapies 48 colorectal cancer incidence 48 cerebral perfusion 48 transferrin saturation 48 attain statistical significance 48 aromatase inhibitor therapy 48 vidofludimus 48 APPRAISE 48 GnRH agonists 48 coagulopathy 48 oral anticoagulant therapy 48 antithrombotic agents 48 urate levels 48 erection hardness 48 NP CRNs 48 parenchymal 48 transesophageal 48 prevalences 48 postoperative complications 48 genetic polymorphism 48 Coronary artery bypass grafting 48 Chlamydia trachomatis infection 48 chest radiographs 48 serum cotinine levels 48 prognostic factor 48 endocrine therapies 48 CI -#.# 48 prefrontal cortical 48 pharmacological therapy 48 aortic insufficiency 48 CORE OM 48 transient elastography 48 interstitial lung abnormalities 48 histological subtypes 48 left ventricular dysfunction 48 NIDDM 48 causative mutation 48 NICE SUGAR 48 plasma lipid 48 multivariate regression 48 adjuvant chemotherapy 47 advanced adenoma 47 skin sparing mastectomy 47 MetS 47 #q# deletion 47 tumor subtypes 47 trials RCTs 47 TRUS biopsy 47 central adiposity 47 hepatotoxicity 47 bacteriuria 47 Helicobacter pylori infection 47 axillary node 47 mGluR5 inhibition 47 atherogenic dyslipidemia 47 MAOA gene 47 breast cancer subtypes 47 T2DM 47 angiography CTA 47 hemodilution 47 prognostic variables 47 cytoreductive nephrectomy 47 Deutsches Arzteblatt International 47 axillary node dissection 47 ultrasonographic 47 oral prednisolone 47 hepatectomy 47 invasive carcinoma 47 highest quintile 47 Asymptomatic 47 SNP rs# [001] 47 Alpha Tocopherol Beta Carotene 47 inhibin B 47 hyperglycaemia 47 electron beam computed tomography 47 nonobese 47 prostatic 47 HeFH 47 viral etiology 47 STEP BD 47 histologically proven 47 bladder carcinoma 47 TMP SMX 47 nasal polyposis 47 neurologic outcomes 47 multimodality therapy 47 serotonin deficiency 47 multicenter trials 47 de ath 47 poorer prognosis 47 Erythropoietic therapies may 47 ascertainment bias 47 lowest quintile 47 FENO 47 HPA axis 47 overactive bladder symptoms 47 % CI #.#-#.# [002] 47 clinically insignificant 47 testicular tumors 47 sacral neuromodulation 47 prophylaxis 47 neoadjuvant 47 aortic calcification 47 adnexal mass 47 recurrent glioblastoma multiforme 47 asymptomatic bacteriuria 47 GI toxicity 47 cerebral oxygenation 47 transvaginal sonography 47 cytoreductive surgery 47 chlamydial 47 CaP 47 periprocedural 47 sociodemographic variables 47 hyperphosphatemia 47 selenium supplementation 47 Cochrane Systematic Review 47 multicenter study 47 plasma folate 47 pathophysiologic 47 intraobserver 47 fibrotic disease 47 incidentalomas 47 reperfusion therapy 47 pesticide exposures 47 hypoperfusion 47 pharmacotherapeutic 47 hydroxyvitamin D levels 47 HF WBI 47 adenomatous polyps 47 glycemia 47 undertreatment 47 adjunct therapy 47 angiotensin II receptor blockers 47 HYVET 47 laterality 47 systolic hypertension 47 acute respiratory tract infections 47 repletion 47 Randomized trials 47 nomograms 47 serum cotinine 47 parasitaemia 47 magnesium intake 47 hypercalciuria 47 Leydig cell 47 pulmonary nodules 47 metabolic disturbances 47 analgesic efficacy 47 prospective observational cohort 47 antithrombotic 47 univariate analysis 47 spontaneous preterm delivery 47 phenotypic expression 47 antiplatelet drugs 47 pathologic 47 macronutrient intake 47 Longitudinal studies 47 FeNO 47 CARDIA study 47 gastric carcinoma 47 Heritability 47 surrogate marker 47 pathophysiologic mechanisms 47 arterial hypertension 47 researchers theorize 47 lung epithelium 47 neuroinflammatory 47 Singh Manoux 47 Randomised controlled trials 47 phenotype 47 insulin sensitizing agents 47 Exacerbations 47 susceptibility locus 47 folate deficiency 47 pulmonary metastases 47 glycoprotein IIb IIIa inhibitors 47 Uncontrolled hypertension 47 modifiable risk 47 normotensive 47 pre malignant lesions 47 causal pathways 47 CTEPH 47 acute myocardial infarction MI 47 dose statin therapy 47 BLLs 47 NNRTI resistance 47 hormone receptor status 47 hemodynamic parameters 47 prognostically 47 fulminant hepatic failure 47 parkinsonian symptoms 47 noncardiac chest pain 47 glucose homeostasis 47 genetic determinants 47 comorbid psychiatric 47 causal relation 47 ventricular hypertrophy 47 VLBW infants 47 lipid lowering medications 47 plasma lipids 47 psychotherapies 47 morphological abnormalities 47 acid suppressive therapy 47 cardioprotective effect 47 FDG PET CT 47 atherogenesis 47 neurologic disorders 47 baseline LDH 47 atopic 47 HRQL 47 atrophic gastritis 47 ovariectomized 47 lumbar disk herniation 47 photoprotection 47 socioeconomic inequalities 47 atheromatous 47 ALI ARDS 47 nondemented 47 CR nPR 47 parathyroidectomy 47 folate concentrations 47 comorbid anxiety 47 dysglycemia 47 preoperative chemotherapy 47 NSTE ACS 47 hypercoagulable 47 stereotactic radiotherapy 47 atypical antipsychotic medications 47 onset diabetes mellitus 47 antitumour 47 convergent validity 47 haematopoietic cells 47 cognitively intact 47 inhaled corticosteroid therapy 47 SOD2 47 Insulin detemir 47 cortical thinning 47 gastro oesophageal reflux 47 logistic regression analysis 47 CP CPPS 47 transcatheter closure 47 pharmacologic therapy 47 neurodevelopmental impairment 47 adjunctive 47 lung cancer chemoprevention 47 serologic testing 47 atopy 47 microvascular disease 47 thromboembolic complications 47 iodine supplementation 47 euthymic patients 47 inhibits platelet aggregation 47 gut microbiota 47 confidence interval #.#-#.# 47 multivessel coronary artery 47 coronary artery stenosis 47 ovarian hormones 47 mTOR inhibition 47 atherothrombotic disease 47 Wernicke Korsakoff syndrome 47 randomized clinical trials 47 albumin excretion 47 MTHFR 47 dietary folate 47 spirometric 47 haematopoietic 47 nonadherence 47 Sentinel node biopsy 47 genetic loci 47 abdominal adiposity 47 pathogenesis 47 squamous cell lung cancer 47 meta analyzes 47 sonographic evaluation 47 observational studies 47 anticholinergic agents 47 mediastinal 47 atopic disorders 47 maladaptive behaviors 47 mixed hyperlipidemia 47 malignant lymphomas 47 platelet reactivity 47 myocardial ischaemia 47 ipsilateral 47 contralateral breast cancer 47 graft patency 47 echocardiographic parameters 47 eprotirome 47 histological subtype 47 thetreatment 47 Post operatively 47 lipid lowering drugs 47 nonfasting triglycerides 47 chromosome #p# [002] 47 subanalysis 47 covariate 47 anticoagulant therapy 47 bile acid metabolism 47 corticosteroid therapy 47 rs# [004] 47 uncircumcised males 47 physiologic mechanisms 47 ABCB1 47 Accelerated Partial Breast Irradiation 47 DHA supplementation 47 primary aldosteronism 47 androgen excess 47 journal BJOG 47 gene polymorphisms 47 lipid profiles 47 Mitochondrial dysfunction 47 antidepressant efficacy 47 transfusion transmitted 47 metabolic dysregulation 47 pulmonary artery banding 47 mutated K ras 47 inactivated influenza vaccines 47 biopsychosocial 47 Clinical Antipsychotic Trials 47 chemoprevention trials 47 trophoblast cells 47 elevated homocysteine 47 hormonally responsive 47 subclinical hyperthyroidism 47 CVD cardiovascular disease 47 prognostic factors 47 immunosuppressive regimens 47 multivariable analyzes 47 coronary artery revascularization 47 LC#m# vaccine 47 distal colon cancer 47 LVNC 47 premenopausal breast cancer 47 MYH9 47 atherosclerotic vascular disease 47 RE LY ® 47 CANCER peer reviewed 47 behavioral interventions 47 allele frequencies 47 antiphospholipid syndrome 47 ultrastructural 47 antioxidant vitamin supplements 47 Acute Coronary Syndromes ACS 47 carotid revascularization 47 genomic alterations 47 antithrombotics 47 placebo controlled trials 47 autologous transplantation 47 moderately heritable 47 Kaplan Meier curves 47 dietary intakes 47 undergoing peritoneal dialysis 47 inadequate calcium intake 47 HepG2 cells 47 prospective multicentre 47 fluoroquinolone resistance 47 Thiazolidinediones 47 neuroleptics 47 ventricular remodeling 47 tertile 47 pulmonary dysfunction 47 dietary calcium 47 biologically plausible 46 hamartomas 46 surgical revascularization 46 ART regimens 46 prophylactic therapy 46 MDRD 46 patients undergoing percutaneous 46 adverse perinatal 46 thyroid nodule 46 BRCA1 mutation carriers 46 ventricular tachyarrhythmia 46 severe periodontitis 46 systemic hypotension 46 psychosocial variables 46 morphologic 46 esophageal squamous cell carcinoma 46 mechanical dyssynchrony 46 eNO 46 renal biopsy 46 C trachomatis 46 Cardiorespiratory fitness 46 supratentorial 46 anatomic abnormalities 46 C#Y 46 estrogen metabolism